Plasminogen activator inhibitor-1 is an independent diagnostic marker as well as severity predictor of hepatic veno-occlusive disease after allogeneic bone marrow transplantation in adults conditioned with busulphan and cyclophosphamide

British Journal of Haematology

Volumn 118, Issue 4, 2002, Pages 1087-1094

  Lee, Je Hwan ^a   Lee, Kyoo Hyung ^a   Lee, Jung Hee ^a   Kim, Shin ^a   Seol, Miee ^a   Park, Chan Jeoung ^a   Chi, Hyun Sook ^a   Kang, Weechang ^a   Kim, Seung Taik ^b   Kim, Woo Kun ^a   Lee, Jung Shin ^a,c  

^a University of Ulsan College of Medicine   (South Korea)

^b Chungbuk National University College of Medicine   (South Korea)

^c Asan Medical Center   (South Korea)

Author keywords

Allogeneic bone marrow transplantation; PAI 1; Veno occlusive disease

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BUSULFAN; CYCLOPHOSPHAMIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BODY WEIGHT; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HEMOSTASIS; HUMAN; LIVER FUNCTION TEST; LIVER VEIN OBSTRUCTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; MULTIVARIATE ANALYSIS; MYELODYSPLASTIC SYNDROME; PREDICTION; PRIORITY JOURNAL; TREATMENT INDICATION;

ADOLESCENT; ADULT; AUTOANTIGENS; BILIRUBIN; BIOLOGICAL MARKERS; BODY WEIGHT; BONE MARROW TRANSPLANTATION; BUSULFAN; CHI-SQUARE DISTRIBUTION; CYCLOPHOSPHAMIDE; FEMALE; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA; LOGISTIC MODELS; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 18544367609     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03748.x     Document Type: Article

References (25)

1. Veno-occlusive disease of the liver complicating bone marrow transplantation
2. The syndrome of hepatic veno-occlusive disease after marrow transplantation
3. Venoocclusive disease of the liver: Development of a model for predicting fatal outcome after marrow transplantation
4. Treatment of hepatic venocclusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients
5. Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: A prospective cohort study of the European Group for Blood and Marrow Transplantation
6. Hypercoagulability in patients undergoing autologous or allogeneic BMT for hematological malignancies
7. Von Willebrand factor as a marker of endothelial cell activation following BMT
8. Factor VIIa and other haemostatic variables following bone marrow transplantation
9. Naturally occurring anticoagulants and bone marrow transplantation: Plasma protein C predicts development of venocclusive disease of the liver
10. High frequency of antithrombin 3 and protein C deficiency following autologous bone marrow transplantation for lymphoma
11. Antithrombin deficiency in special clinical syndromes - Part II: Hematologic malignancies and bone marrow transplantation
12. Changes in the natural anticoagulants following bone marrow transplantation
13. Serum procollagen type III is an early and sensitive marker for veno-occlusive disease of the liver in children undergoing bone marrow transplantation
14. Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin (ogen) degradation products
15. Randomized comparison of two different schedules of granulocyte colony-stimulating factor administration after allogeneic bone marrow transplantation
16. Relevance of proteins C and S, antithrombin III, von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing allogeneic bone marrow transplantation: A prospective study
17. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation for severe aplastic anemia
18. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: A cohort study of 355 patients
19. Changes in hemostatic parameters in hepatic veno-occlusive disease following bone marrow transplantation
20. Parameters of the fibrinolytic system in patients undergoing BMT: Elevation of PAI-1 in veno-occlusive disease
21. Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation
22. Liver veno-occlusive disease after bone marrow transplantation changes in coagulation parameters and endothelial markers
23. Increased levels of tissue plasminogen activator (t-PA) and tissue plasminogen activator inhibitor (PAI) correlate with tumor necrosis factor alpha (TNF alpha)-release in patients suffering from microangiopathy following allogeneic bone marrow transplantation (BMT)
24. An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation
25. Hepatic veno-occlusive disease after bone marrow transplantation. Immunohistochemical identification of the material within occluded central venules